Document is current

Article History

Received: 28 February 2022

Revised: 7 April 2022

Accepted: 7 April 2022

First Online: 12 April 2022

Declarations

:

: Dr. Vemuri received speaker fees from Miller Medical Communications, Inc. and receives research support from the NIH. Dr. Graff-Radford serves as an assistant editor for Neurology and receives research support from the NIH. Dr. Lowe consults for Bayer Schering Pharma, Piramal Life Sciences, Life Molecular Imaging, Eisai Inc., AVID Radiopharmaceuticals, and Merck Research and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals and the NIH. Dr. Murray served as a consultant for AVID Radiopharmaceuticals. Dr. Mielke serves as a consultant for Biogen and Brain Protection Company and receives research funds from the NIH and DOD. Dr. Machulda receives research support from NIH. Dr. Petersen serves as a consultant for Roche Inc., Merck Inc., and Biogen, Inc., serves on the Data Safety Monitoring Board for Genentech, Inc., and receives a royalty from Oxford University Press and UpToDate. Dr. Knopman serves on a Data Safety Monitoring Board for the DIAN study, serves on a Data Safety Monitoring Board for Biogen but receives no personal compensation, is an investigator in clinical trials sponsored by Biogen, Lilly Pharmaceuticals, and the University of Southern California, and serves as a consultant for Roche, Samus Therapeutics, Third Rock and Alzeca Biosciences but receives no personal compensation. Dr. Jack serves on an independent data monitoring board for Roche, has served as a speaker for Eisai, and consulted for Biogen, but he receives no personal compensation from any commercial entity. He receives research support from NIH and the Alexander Family Alzheimer’s Disease Research Professorship of the Mayo Clinic. The remaining authors report no relevant financial disclosures.